Jahnavi Kharidia

Jahnavi Kharidia serves as a Senior Director at Alkermes since May 2023, bringing extensive expertise in clinical pharmacology from previous roles at Avidity Biosciences, Inc., Indivior Pharmaceuticals, Infinity Pharmaceuticals, and Sunovion Pharmaceuticals Inc. Jahnavi's responsibilities include contributing to clinical development plans and regulatory submissions, as well as designing innovative early clinical development strategies for new drug candidates. The career history includes serving as a Project Officer at NIDA/NIH, focusing on drug abuse treatment programs, and as a Reviewer at the FDA, specializing in biopharmaceutics and pharmacokinetics. Education includes an MBA from Virginia Commonwealth University, a Ph.D. in Pharmaceutical Science from the University of Maryland Baltimore, and multiple pharmacy-related certifications.